Complexity and Ethics of Gene Editing WHAT IS GENE EDITING? Human Gene Manipulation: Screening GLOBAL FERTILITY NEUROTRANSMITTER DISORDERS SECOND LAW FAT AND LIFE Water and Magic THE RANDOM AND THE STABLE IN CHEMISTRY-BASED LIFE Why Healthcare Cannot Be a Completely Free Market Tutorial on the Regulation of the Pharmaceutical Industry Two Visions for Healthcare How…
What does gene editing mean for society? How complex is the procedure? What is the likelihood that mistakes will be made in the process? What happens to discarded embryos?
The book you are seeing on your screen may look like a normal book; it is not. It is a conversation in which you are a participant. The book does not offer pat answers to hard questions. In fact, it barely even gives definition to hard questions. Rather, this book presents that stage in which science is most challenging and, arguably, most interesting—the period of identifying just what the problems and issues are. That is why we solicit your help in writing this story—the story of extreme events in social systems.
The participants in this book-writing enterprise are independent thinkers who wish to understand the forces impinging on social systems and the systems’ often dramatic and extreme responses to those forces. Extreme events, the sudden and discontinuous response of social systems to these forces, are what we for shorthand term X-Events. X-events We imagine the reader to be a person who wants to intelligently manage his or her actions and behaviors in the midst of an X-event—in short, to manage an organization in chaos. And not only manage, but be a beneficiary of that event. Explicitly, we understand that there are no simple answers to social questions. But but there is at least a gestalt that can help an individual anticipate and manage X-events. The program outlined here is to build the gestalt by total immersion in the topic—by examining the issues from many perspectives.
We live in a world of abundance. What are the implications?
Read more in Confronting Complexity by Casti, Jones, and Pennock
We live in a world of abundance, but is it really the land of Rainbow Pie? What surprises have we seen? How do we map out the land of abundance to understand the unintended consequences?
Hello fellow space-time travelers. My name is Roger Jones. I am coming to you from steamy downtown Pensacola, Florida. It is 7:30 in the morning in late June, so you can see the morning sun streaming through the east-facing windows behind me. This is the first post on this channel, TheX-Press channel, so I thought…
This video tells a story, a parable rather, about abundance of water and the consequences of abundant water. The setting is Pensacola, Florida. This video is part of the Abundance Project in which citizens are invited to participate in critical thinking to create tools for policy makers.
A price is paid for the abundance, however. The complexity of 21st-century life increased, making many people uncomfortable with their new high-energy environment. Gradients in the distribution of abundance annoyed many more people. A populist groundswell developed around the world with the stated goal to return to simpler times.
The very first obstacle that must be overcome to reunite the children with the families is to remove the parents from detention. This can be done with a bond. A bond releases the parents from detention. Once free, they are allowed to seek out their children, which is another set of hurdles.
The concept of supply and demand is the cornerstone of economic theory. For simple commodities, the theory predicts that the demand for a product decreases as the price of the product increases and consumers are unwilling to pay the higher price. The supply increases as the price increases and suppliers increase production to capture increased profits. The actual price of the product is a compromise between the desires of consumers and the acumen of suppliers.
The pharmaceutical market place is not entirely a free market. The extreme demand for lifesaving products can make standard economic assumptions inoperable. Therefore, regulatory mechanisms have emerged to protect patients and to provide patients access to affordable medications. There are three aspects of pharmaceutical operations in the U.S. that are regulated by the government: